MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Gait impairment as predictor of falls in patients with early Parkinson’s disease

    I. Stankovic, V. Markovic, S. Radovanovic, I. Petrovic, N. Dragasevic, M. Svetel, E. Stefanova, V. Kostic (Belgrade, Serbia)

    Objective: To prospectively investigate disease progression in the early-stage Parkinson’s disease (PD) patients who fall (PD-Falls) and do not fall (PD-NoFalls) in the fifth year…
  • MDS Virtual Congress 2021

    MICROBIAL TRANSLOCATION IN PATIENTS WITH PARKINSON DISEASE AT THE UNIVERSITY TEACHING HOSPITAL, LUSAKA, ZAMBIA: A CASE CONTROL STUDY

    L. Chishimba, E. Sinkala, P. Kelly, M. Atadzhanov (Lusaka, Zambia)

    Objective: To study the association of microbial translocation in patients with Parkinson disease in Zambia. Background: Over the past few years evidence has emerged that…
  • MDS Virtual Congress 2021

    Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson’s disease

    N. Witek, J. Joyce, J. Hawkins, Y. Liu, B. Ouyang, R. Patel, J. Borgia, J. Reiser, D. Hall (Chicago, USA)

    Objective: The objective of this study was to assess if soluble urokinase-type plasminogen activator receptor (SuPAR) is elevated in patients with Parkinson's disease (PD). Background:…
  • MDS Virtual Congress 2021

    Health instruction in Parkinson’s disease with an emphasis on the quality of life using eHealth strategies in the context of COVID-19

    J. Biernaski, S. Souza, D. Baptista, M. Borato, N. Cuduh, J. Pelegrini, A. Silva, V. Israel (Curitiba, Paraná, Brazil)

    Objective: To develop an eHealth Physiotherapy Program (ePhysio) for remote health instruction to promote the quality of life (QOL) of people with Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    INTERLEUKIN 4 (IL-4),INTERLEUKIN 1α (IL-1α) AND CORTISOL SERUM LEVELS IN PARKINSON’S DISEASE PATIENTS UNDERGOING DANCE THERAPY

    K. Marques, J. Duarte, G. Bahia, B. Dos Santos-Lobato, L. Krejcová, C. Bahia (Belém, Brazil)

    Objective: To identify changes in anti and pro-inflammatory cytokines and cortisol hormone levels in patients with Parkinson's disease undergoing dance therapy. Background: Parkinson’s disease(PD) pathophysiology…
  • MDS Virtual Congress 2021

    Telemonitoring physical exercise program during COVID-19 pandemic for individuals with Parkinson’s disease: adherence rate, barriers to attend, safety and overall experience.

    C. Torriani-Pasin, V. Domingues, T. Freitas, T. Silva, M. Caldeira, R. Júnior, A. Lara, B. Araujo, G. Palma, M. Makhoul, L. Mochizuki (São Paulo, Brazil)

    Objective: To evaluate adherence rate, barriers to attendance, and safety of a telemonitoring physical exercise program for individuals with Parkinson’s disease (PD); To evaluate the…
  • MDS Virtual Congress 2021

    A Pandemic Care Partner Summit: Online Program Helps Parkinson’s Care Partners Take Positive Actions

    D. Perret, A. Wallis (Miami, USA)

    Objective: The Parkinson’s Foundation Care Partner Summit | Cumbre Para Cuidadores was held virtually on May 16, 2020 in the height of the COVID-19 Pandemic.…
  • MDS Virtual Congress 2021

    The satisfaction with life and treatment scale (SLTS-7) in patients with Parkinson’s disease

    A. Sauerbier, P. Bachon, L. Ambrosio, P. Leohrer, A. Rizos, S. Jost, A. Gronostay, A. Konitsioti, M. Barbe, G. Fink, K. Ashkan, C. Nimsky, V. Visser-Vandewalle, K. Ray Chaudhuri, L. Timmermann, P. Martinez-Martin, H. Dafsari (Köln, Germany)

    Objective: To explore a new rating tool to assess satisfaction with life and treatment (SLTS-7) in a PD population. Background: The satisfaction with life and in…
  • MDS Virtual Congress 2021

    Subthalamic nucleus deep brain stimulation implant hemisphere differentially changes verbal fluency in patients with Parkinson disease

    V. Del Bene, D. Marotta, R. Martin, C. Gonzalez, J. Bentley, B. Guthrie, S. Black, M. Nelson, H. Walker (Birmingham, USA)

    Objective: To investigate verbal fluency following unilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in patients with Parkinson’s disease (PD). Background: Verbal fluency declines in…
  • MDS Virtual Congress 2021

    Deep brain stimulation improves gait velocity acutely in patients with Parkinson’s disease

    S. Miocinovic, L. Mckay, F. Isbaine, J. Nocera, J. Tran, S. Triche, C. Esper, P. Aia, L. Scorr, L. Higginbotham, C. Buetefisch (Atlanta, USA)

    Objective: To systematically investigate the acute (5 minutes) and chronic (1 month) effects of deep brain stimulation (DBS) of subthalamic nucleus (STN) and globus pallidus…
  • « Previous Page
  • 1
  • …
  • 292
  • 293
  • 294
  • 295
  • 296
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley